Boosters for all adults, conflicting advice

WHO advice on boosters, Link to free download my 2 textbooksUploaded 19-11-21http://159.69.48.3/https://www.youtube.com/watch?v=uGCK8Z27xd0No country can simply vaccinate its way out of the pandemicIts not vaccine ‘or’Its vaccines ‘and’It makes no sense to give boosters to healthy adults(when high risk around the world are still wating for their first dose)Every day there are 6 times more booster doses administered than primary doses in poorer countriesThis is a scandal that must stop nowFood and Drug Administrationhttps://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boostershttps://www.cdc.gov/vaccines/acip/index.htmlAmended the emergency use authorizations (EUA) for Moderna and PfizerModerna (half of the primary dose)A single booster dose for all 18 and olderActing FDA Commissioner Janet Woodcockhelps to provide continued protection against COVID-19, including the serious consequences that can occur, such as hospitalization and deathAt least six months after primary vaccination seriesAt least two months after JanssenData Supporting EffectivenessModerna, FDA analysisStudy groupN= 149 from the original clinical studies who received a boosterControls groupN = 1,055 two-dose seriesResultThe antibody response against the SARS-CoV-2 virus 29 days after a booster dose of the vaccine demonstrated a booster response. Pfizer-BioNTechStudy groupN= 200 who received a boosterControls groupSame people, one month after the two-dose primary seriesResultThe antibody response demonstrated a booster response.FDA Evaluation of Benefits and RisksAdditional real-world data,on the recently increasing number of cases of COVID-19 in the U.S.and on the risk of myocarditis and pericarditis following vaccinationThe FDA has determined that the benefits of a single booster dose of either the Moderna or Pfizer-BioNTech COVID-19 vaccinesoutweigh the risks of myocarditis and pericarditisin individuals age 18 years of age and olderBoth Pfizer and Moderna are conducting post-authorization/post-marketing studiesto assess known serious risks of myocarditis and pericarditis. FDA and the CDC have several systems in place to continually monitor COVID-19 vaccine safetyMost commonly reported side effects after a boosterPain, redness and swelling at the injection siteFatigue, headache, muscle or joint pain and chillsSwollen lymph nodes in the underarm, more frequently following the boosterAustriahttps://www.telegraph.co.uk/world-